The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users (Q48319552)

10 February 2018

MDMA

0 references

title

The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users (English)

1 reference

10 February 2018

author name string

Una D McCann

series ordinal

1

1 reference

10 February 2018

Stephen C Peterson

series ordinal

2

1 reference

10 February 2018

George A Ricaurte

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

3 January 2007

1 reference

10 February 2018

published in

Neuropsychopharmacology

1 reference

10 February 2018

volume

32

1 reference

10 February 2018

issue

8

1 reference

10 February 2018

page(s)

1695-1706

1 reference

10 February 2018

A simple objective technique for measuring flexibility in thinking.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Neural substrates of faulty decision-making in abstinent marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Memory impairment in abstinent MDMA ("Ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Regulation of adolescent sleep: implications for behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Neurochemical modulation of response inhibition and probabilistic learning in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Serotonin-dopamine interaction as a focus of novel antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

MDMA alters the response of the mammalian circadian clock in hamsters: effects on re-entrainment and triazolam-induced phase shifts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Hypothalamic–pituitary–adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine (‘ecstasy’) use history: correlation with dopamine receptor sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Selective effects of acute serotonin and catecholamine depletion on memory in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Prospective memory, everyday cognitive failure and central executive function in recreational users of Ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Simultaneous depletion of serotonin and catecholamines impairs sustained attention in healthy female subjects without affecting learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Sleep deprivation and impaired cognition. Possible role of brain catecholamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Psychiatric aspects of impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Sleep and risk-taking behavior in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Decreased pain tolerance and mood in recreational users of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Human research on MDMA (3,4-methylene- dioxymethamphetamine) neurotoxicity: cognitive and behavioural indices of change

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Chemistry of the mind: neurochemical modulation of prefrontal cortical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

The impact of regular ecstasy use on memory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Cognitive performance and serotonergic function in users of ecstasy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Serotonergic modulation of neuronal responses to behavioural inhibition and reinforcing stimuli: an fMRI study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Impaired executive function in male MDMA ("ecstasy") users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Memory impairment in abstinent MDMA ("Ecstasy") users: a longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

Brain inhibitory mechanisms involved in basic and higher integrated sleep processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

7 January 2021

5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

7 January 2021

A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

7 January 2021

Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (+/-)-MDMA neurotoxicity: protection by fluoxetine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301302

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301302

1 reference

10 February 2018

1 reference

10 February 2018